Travocort Cream

Travocort Cream is supplied as a cream, with Diflucortolone valerate and Isoconazole nitrate. It is supplied in a pack size of 10g.

No prescription is required for this product, as it is a non-prescription medicine. This page is limited to product, safety and handling information.

If you would like guidance before buying, you can speak to a doctor or pharmacist through an online consultation on DoctorOnCall. Orders are dispensed by a registered pharmacist and delivered to your address.

Use Travocort Cream only as prescribed by your doctor following an online consultation. Clean and dry the affected area, then apply a thin layer of cream and gently rub it in, usually twice daily (morning and evening) unless your doctor advises otherwise. Continue treatment for the full course prescribed even if the itching and redness improve quickly, since stopping too early can allow the fungal infection to persist or return.

Treatment is typically applied twice daily for around 1 to 2 weeks, after which many prescribers will advise switching to an antifungal-only cream (without the steroid) to complete the full antifungal course once the inflammation has settled, to avoid prolonged steroid use on the skin. Do not use for longer than your doctor has prescribed, and do not restart it for a new episode without checking in again, as the diagnosis should be reconfirmed.

Travocort Cream is generally stable for up to 2 to 3 years from the date of manufacture when unopened and stored correctly; always check the expiry date printed on the tube and outer carton and do not use the product beyond this date.

Store Travocort Cream below 25°C in a cool, dry place away from direct sunlight, with the tube tightly closed after each use. Keep out of reach and sight of children, and do not use if the cream’s colour or consistency appears to have changed.

• Known hypersensitivity to diflucortolone valerate, isoconazole nitrate, or any other ingredient in the cream
• Untreated bacterial or viral skin infections (including tuberculosis of the skin, chickenpox, shingles or herpes simplex) at the site to be treated
• Use on the face for prolonged periods, or on thin-skinned areas like the groin and armpits for longer than prescribed, without close doctor supervision
• Acne, rosacea, or perioral dermatitis, which can worsen with corticosteroid use
• Use on large areas of broken or infected skin without medical supervision

• Combining Travocort Cream with other topical corticosteroids increases the risk of skin thinning and should be avoided unless directed by your doctor
• Using occlusive dressings or tight bandages over treated skin increases absorption of both ingredients and the risk of side effects, and should only be done if specifically instructed
• Other topical antifungal or antibacterial products applied to the same area at the same time may reduce effectiveness or increase irritation; space out or avoid unless advised
• Inform your doctor about all other topical, oral, or systemic corticosteroid or antifungal medicines you are using

• Complete the full course prescribed, even if symptoms improve quickly, to fully clear the fungal infection
• Apply only a thin layer to clean, dry skin, usually twice daily as directed
• Avoid using on the face, groin or armpits for longer than prescribed without your doctor’s guidance
• Do not share this cream with others, even if their rash looks similar
• Seek medical advice if the rash worsens, spreads, or does not improve within the prescribed treatment period
• Ask your doctor whether to switch to an antifungal-only cream once inflammation has settled

Travocort Cream combines a potent steroid with an antifungal specifically for short-term use on inflamed fungal infections, and is not intended as a general-purpose antifungal or steroid cream for unrelated skin conditions. Because misdiagnosed or prolonged steroid use can worsen a fungal infection (a phenomenon sometimes called tinea incognito) or cause skin thinning, follow-up with your prescribing doctor through DoctorOnCall is recommended if symptoms do not fully resolve within the expected treatment period, so the diagnosis and treatment plan can be reassessed.